newsfilter
← Latest News
Business Wire·

Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

The Company's cash guidance is now extended into 2027 Company to host conference call and webcast today at 8 a.m. EST / 1 p.m. GMT Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), a global